Granulomatosis with Polyangiitis
📧 Sign up to get email alerts when something new happens for Granulomatosis with Polyangiitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-01-18FDA Approved: CYCLOPHOSPHAMIDE — Original Application (Cipla USA Inc.)
The FDA approved Cipla USA Inc.'s original application for a generic cyclophosphamide product. This marks approval of a generic formulation …
-
CLINICAL_TRIALS trial_result · 2018-08-17Clinical Trial Update: Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis [Phase 4]
A Phase 4 pilot study evaluating short-course glucocorticoids plus rituximab for ANCA-associated vasculitis has completed with posted result…
-
CLINICAL_TRIALS research · 2018-06-06Clinical Trial Update: Journey of Patients With Vasculitis From First Symptom to Diagnosis
A completed University of Pennsylvania clinical study tracks vasculitis patients from first symptoms through diagnosis, describing the diagn…
-
CLINICAL_TRIALS trial_result · 2018-03-22Clinical Trial Update: Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis [Phase 4]
The Phase 4 trial evaluating Rituximab for otolaryngologic manifestations of granulomatosis with polyangiitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-10-27Clinical Trial Update: Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study
This clinical trial update reports long-term follow-up results from the RAVE study evaluating rituximab for ANCA-associated vasculitis, incl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2017-06-22FDA Approved: RITUXAN HYCELA — Original Application (Genentech, Inc.)
FDA approved RITUXAN HYCELA (rituximab and hyaluronidase) under an Original Application by Genentech. The subcutaneous formulation provides …
-
FDA label_change · 2017-06-22FDA Approved: RITUXAN HYCELA — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Rituxan Hycela (rituximab and hyaluronidase) by Genentech, updating the labeling for this subcut…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: The ANCA Vasculitis Questionnaire (AAV-PRO©)
The ANCA Vasculitis Questionnaire (AAV-PRO©) trial update notes that the study evaluating a patient-reported outcome instrument for ANCA-ass…
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: Phase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis [Phase 2]
Phase II study of Gusperimus in patients with refractory granulomatosis with polyangiitis (Wegener's granulomatosis) has been completed; res…
-
CLINICAL_TRIALS research · 2016-08-19Clinical Trial Update: American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis
This clinical trial update describes progress on the ACR/EULAR diagnostic and classification criteria for primary systemic vasculitis, spons…
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
An observational safety study evaluated rituximab (MabThera/Rituxan) in granulomatosis with polyangiitis and microscopic polyangiitis. The s…
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Impact of Vasculitis on Employment and Income
This completed clinical trial update examines how vasculitis and its subtypes impact employment and income for patients.
-
CLINICAL_TRIALS withdrawal · 2015-07-30Clinical Trial Update: BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis [Phase 2]
A Phase 2 trial evaluating blisibimod added to methotrexate for induction of remission in ANCA-associated small vessel vasculitis (granuloma…
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD") [Phase 4]
Phase 4 trial evaluating interventional cryotherapy to eradicate benign airway disease; terminated with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's Granulomatosis [Phase 3]
A Phase 3 clinical study comparing gusperimus with conventional treatment for granulomatosis with polyangiitis (Wegener's granulomatosis) ha…
-
CLINICAL_TRIALS research · 2015-05-28Clinical Trial Update: PRO Development for ANCA Associated Vasculitis
Clinical trial update describing the development of a patient-reported outcome measure for ANCA-associated vasculitis.
-
CLINICAL_TRIALS research · 2014-07-15Clinical Trial Update: Educational Needs of Patients With Systemic Vasculitis
The document reports on a completed clinical trial evaluating the educational needs and resources for patients with systemic vasculitis.
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Vasculitis Illness Perception (VIP) Study
The Vasculitis Illness Perception (VIP) study has completed. The update lists several vasculitis conditions studied, including granulomatosi…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Reproductive Health in Men and Women With Vasculitis
A completed clinical trial evaluating reproductive health in men and women with various forms of vasculitis.
-
CLINICAL_TRIALS research · 2014-04-29Clinical Trial Update: Observation Study of Clinical Manifestation and Outcome in Chinese Patients With Pulmonary Vasculitis
An observational study update on pulmonary vasculitis in Chinese patients, describing clinical manifestations and outcomes across ANCA-assoc…
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis [Phase 1, Phase 2]
Abatacept was studied in adults with mild relapsing granulomatosis with polyangiitis (GPA) in Phase 1/2 trials; the study has completed and …
-
CLINICAL_TRIALS trial_result · 2011-09-12Clinical Trial Update: Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years [Phase 4]
A Phase 4 clinical trial update from Assistance Publique - Hôpitaux de Paris evaluating treatment for necrotizing vasculitides in patients a…
-
CLINICAL_TRIALS trial_result · 2011-08-25Clinical Trial Update: Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis [Phase 2, Phase 3]
Phase 2/3 trial update assessing rituximab for granulomatosis with polyangiitis and microscopic polyangiitis. The study is completed with re…
-
CLINICAL_TRIALS trial_result · 2011-08-03Clinical Trial Update: Plasma Exchange for Renal Vasculitis [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating plasma exchange for renal vasculitis (granulomatosis with polyangiitis and microscopic polyangiitis) h…
-
CLINICAL_TRIALS trial_result · 2011-07-29Clinical Trial Update: Alemtuzumab for ANCA Associated Refractory Vasculitis [Phase 4]
Phase 4 clinical trial update evaluating alemtuzumab for ANCA-associated refractory vasculitis; the study includes microscopic polyangiitis …